633 related articles for article (PubMed ID: 10845624)
1. Glial reactivity, an early feature of diabetic retinopathy.
Rungger-Brändle E; Dosso AA; Leuenberger PM
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1971-80. PubMed ID: 10845624
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.
Barber AJ; Antonetti DA; Gardner TW
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3561-8. PubMed ID: 11006253
[TBL] [Abstract][Full Text] [Related]
3. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy.
Yang LP; Sun HL; Wu LM; Guo XJ; Dou HL; Tso MO; Zhao L; Li SM
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2319-27. PubMed ID: 19011009
[TBL] [Abstract][Full Text] [Related]
4. Early retinal damage in experimental diabetes: electroretinographical and morphological observations.
Li Q; Zemel E; Miller B; Perlman I
Exp Eye Res; 2002 May; 74(5):615-25. PubMed ID: 12076083
[TBL] [Abstract][Full Text] [Related]
5. The Ins2Akita mouse as a model of early retinal complications in diabetes.
Barber AJ; Antonetti DA; Kern TS; Reiter CE; Soans RS; Krady JK; Levison SW; Gardner TW; Bronson SK
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2210-8. PubMed ID: 15914643
[TBL] [Abstract][Full Text] [Related]
6. High-salt loading exacerbates increased retinal content of aquaporins AQP1 and AQP4 in rats with diabetic retinopathy.
Qin Y; Xu G; Fan J; Witt RE; Da C
Exp Eye Res; 2009 Nov; 89(5):741-7. PubMed ID: 19596320
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW
Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628
[TBL] [Abstract][Full Text] [Related]
8. A decrease in retinal progenitor cells is associated with early features of diabetic retinopathy in a model that combines diabetes and hypertension.
Lopes de Faria JM; Silva KC; Boer PA; Cavalcanti TC; Rosales MA; Ferrari AL; Lopes de Faria JB
Mol Vis; 2008 Sep; 14():1680-91. PubMed ID: 18806882
[TBL] [Abstract][Full Text] [Related]
9. Normalization of retinal vascular permeability in experimental diabetes with genistein.
Nakajima M; Cooney MJ; Tu AH; Chang KY; Cao J; Ando A; An GJ; Melia M; de Juan E
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2110-4. PubMed ID: 11481279
[TBL] [Abstract][Full Text] [Related]
10. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
Cui B; Sun JH; Xiang FF; Liu L; Li WJ
Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
[TBL] [Abstract][Full Text] [Related]
11. Endothelial F-actin cytoskeleton in the retinal vasculature of normal and diabetic rats.
Yu PK; Yu DY; Cringle SJ; Su EN
Curr Eye Res; 2005 Apr; 30(4):279-90. PubMed ID: 16020258
[TBL] [Abstract][Full Text] [Related]
12. Expression of ciliary neurotrophic factor activated by retinal Müller cells in eyes with NMDA- and kainic acid-induced neuronal death.
Honjo M; Tanihara H; Kido N; Inatani M; Okazaki K; Honda Y
Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):552-60. PubMed ID: 10670488
[TBL] [Abstract][Full Text] [Related]
13. Fibrocontractive Müller cell phenotypes in proliferative diabetic retinopathy.
Guidry C; King JL; Mason JO
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1929-39. PubMed ID: 19117921
[TBL] [Abstract][Full Text] [Related]
14. Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes.
Feit-Leichman RA; Kinouchi R; Takeda M; Fan Z; Mohr S; Kern TS; Chen DF
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4281-7. PubMed ID: 16249509
[TBL] [Abstract][Full Text] [Related]
15. Immunohistologic evidence for retinal glial cell changes in human glaucoma.
Wang L; Cioffi GA; Cull G; Dong J; Fortune B
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1088-94. PubMed ID: 11923250
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of the atrial natriuretic peptide/natriuretic peptide receptor-C system in the early stages of diabetic retinopathy in the rat.
Rollín R; Mediero A; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2005 Mar; 11():216-24. PubMed ID: 15789000
[TBL] [Abstract][Full Text] [Related]
17. Purinergic receptor activation inhibits osmotic glial cell swelling in the diabetic rat retina.
Wurm A; Iandiev I; Hollborn M; Wiedemann P; Reichenbach A; Zimmermann H; Bringmann A; Pannicke T
Exp Eye Res; 2008 Oct; 87(4):385-93. PubMed ID: 18687327
[TBL] [Abstract][Full Text] [Related]
18. Glial cell reactivity in a porcine model of retinal detachment.
Iandiev I; Uckermann O; Pannicke T; Wurm A; Tenckhoff S; Pietsch UC; Reichenbach A; Wiedemann P; Bringmann A; Uhlmann S
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2161-71. PubMed ID: 16639028
[TBL] [Abstract][Full Text] [Related]
19. VEGF-initiated blood-retinal barrier breakdown in early diabetes.
Qaum T; Xu Q; Joussen AM; Clemens MW; Qin W; Miyamoto K; Hassessian H; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2408-13. PubMed ID: 11527957
[TBL] [Abstract][Full Text] [Related]
20. [Changes of tight junction protein and GFAP in the retina of experimental diabetic rats and their relationship with blood aqueous barrier].
Ma HJ; Luo Y; Wang M; Liang XL; Huang CX; Li T; Ding XY; Tang SB
Zhonghua Yan Ke Za Zhi; 2007 May; 43(5):397-401. PubMed ID: 17706086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]